Bing

SEARCH HISTORY

Covance Inc. (CVD)’S monthly performance stands at 3.47% with an analyst rating of 2.90 (Current Stock Info:) Insulet Corporation (PODD) of the Healthcare sector (Medical Instruments & Supplies) has changed by -2.67% ( 0.52% since open) at mid-day …
wallstreetscope.com · 1/14/2015
What Does This Company Do? Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary small molecule drugs to treat serious unmet medical needs, mainly in oncology.
Morning Star · 3/17/2015
As a number of stocks rise and fall today following ... stock price run-ups this year. The companies are among more than a hundred publicly traded biotech firms testing cancer treatments. Incyte (INCY) showed positive results for its drug ruxolitinib ...
Minyanville · ByBrett Chase · 5/19/2011
More from Bing News
David W. Gryska MBA 27 Relationships Chief Financial Officer and Executive Vice President 59 James M. Daly MBA 15 Relationships Chief Commercial Officer and Executive Vice President 52 Reid M. Huber Ph.D. 10 Relationships Chief Scientific Officer …
Bloomberg · 2/3/2015
Advaxis, Inc. (NASDAQ:ADXS), has entered into a clinical trial collaboration agreement with Incyte Corporation (Nasdaq:INCY) to evaluate the combination ... whereby it will repurchase $5 billion of its common stock. Pfizer Inc. (NYSE:PFE) in last trading ...
Property Mentor Group · 2/12/2015
The stock markets in the United States declined as investors continue to monitor corporate earnings report. They are looking for signs of the strength of the bull market. The U.S. bull market hasn’t experienced a 10% correction since 2011, according to ...
Value Walk · ByMarie Cabural · 4/13/2015
Live Webcast Available Starting at 9:15 am ET Incyte Launches ‘Voices of MPN’ Initiative to Unite, Connect and Support Community Affected by Rare Blood Cancers: Myeloproliferative Neoplasms (MPNs) Incyte Corporation (Nasdaq:INCY) will ring the …
Reuters · 9/3/2013
Three weeks ago we checked in on the largest stocks (by market cap) in the soaring Biotechnology ... Up almost 3000% since the 2009 low and +238% in the last 9 months, INCY has been a winning Biotech lotto ticket. That said, February and March haven ...
seeitmarket.com · 3/16/2014
GT Advanced Technologies (GTAT): It's too hot, said Cramer. I just can't endorse this stock up here. Sunedison (SUNE): It's a solar and semi play, said Cramer. It's another stock that's too hot. Getty Images Incyte (INCY): It's a smokin' hot biotech stock ...
CNBC · ByLee Brodie · 3/6/2014
but we believe strong data with a once daily dose may be necessary to ensure strong commercial success against products such as Eli Lilly (LLY)/Incyte’s (INCY) once-daily baricitinib and Pfizer’s (PFE) twice-daily Xeljanz. Shares of AbbVie have gained ...
Barron's · 4/15/2015